Dr. Vivek Samal

Dr. Vivek Samal has a diverse work experience spanning over 15 years in the pharmaceutical industry. Dr. Vivek currently serves as the Executive Director - Patient Safety at ILiAD Biotechnologies, LLC since 2023. Prior to this, they worked as the Senior Director - Global Drug Safety Lead at FibroGen, Inc. from 2022 to 2023, where they were responsible for the global safety strategy and overall safety profile of assigned programs/products. Dr. Samal also has experience working at GSK, where they held roles such as Global Senior Safety Physician from 2016 to 2022 and Global Senior Manager, Global Commercialisation / Development Team, Paediatric Vaccines from 2012 to 2016. Dr. Vivek has also worked at Bristol-Myers Squibb as Associate Director Medical Affairs in 2012 and Merck Sharp & Dohme, where they served as a Medical Affairs Manager and National Manager, Scientific Affairs Team from 2008 to 2012. Additionally, they have previous experience in Medico Marketing at Wockhardt in 2008.

Dr. Vivek Samal completed their MBBS and MD in Pharmacology and Toxicology from 1996 to 2007. In addition, they obtained certifications in various areas such as Business Analyst and Project Manager Collaboration, Collaborative Leadership, Six Sigma: Green Belt, Unconscious Bias, Python programming language, and R programming language. The specific years and months of the certifications are not provided.